ES2056565T3 - Virus recombinante de la enfermedad de marek. - Google Patents

Virus recombinante de la enfermedad de marek.

Info

Publication number
ES2056565T3
ES2056565T3 ES91201796T ES91201796T ES2056565T3 ES 2056565 T3 ES2056565 T3 ES 2056565T3 ES 91201796 T ES91201796 T ES 91201796T ES 91201796 T ES91201796 T ES 91201796T ES 2056565 T3 ES2056565 T3 ES 2056565T3
Authority
ES
Spain
Prior art keywords
marek
disease
recombinant viruses
virus
protoplasm
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91201796T
Other languages
English (en)
Inventor
Robin Wilson Morgan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Application granted granted Critical
Publication of ES2056565T3 publication Critical patent/ES2056565T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

LA INVENCION ACTUAL SE REFIERE AL USO DEL TIPO I DEL VIRUS DE LA ENFERMEDAD DE MAREK COMO VECTOR VIRAL CAPAZ DE EXPRESAR GENES EXTRAÑOS EN ALGUNAS AVES. SE RECLAMA UNA REGION DE INSERCION NO ESENCIAL DEL GENOMA DNA DEL VIRUS; UN PROTOPLASMA QUE COMPRENDE ESTA REGION; UNA CELULA HUESPED QUE CONTIENE EL PROTOPLASMA Y UNA VACUNA QUE COMPRENDE EL VIRUS RECOMBINADO.
ES91201796T 1990-07-30 1991-07-10 Virus recombinante de la enfermedad de marek. Expired - Lifetime ES2056565T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US55973590A 1990-07-30 1990-07-30

Publications (1)

Publication Number Publication Date
ES2056565T3 true ES2056565T3 (es) 1994-10-01

Family

ID=24234797

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91201796T Expired - Lifetime ES2056565T3 (es) 1990-07-30 1991-07-10 Virus recombinante de la enfermedad de marek.

Country Status (11)

Country Link
EP (1) EP0473210B1 (es)
JP (1) JP3159476B2 (es)
KR (1) KR0153005B1 (es)
CN (1) CN1056879C (es)
AU (1) AU645333B2 (es)
CA (1) CA2047290C (es)
DE (1) DE69101683T2 (es)
ES (1) ES2056565T3 (es)
HU (1) HU219377B (es)
NZ (1) NZ239146A (es)
ZA (1) ZA915563B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965138A (en) * 1985-09-06 1999-10-12 Syntro Corporation Recombinant chimeric virus and uses thereof
US5928648A (en) * 1985-09-06 1999-07-27 Syntro Corporation Recombinant herpesvirus of turkeys and uses thereof
US6087127A (en) * 1990-08-24 2000-07-11 Board Of Trustees Operating Michigan State University Marek's disease herpesvirus DNA segment encoding glycoproteins, gD, gI and gE
FR2666589B1 (fr) * 1990-09-07 1994-08-05 Rhone Merieux Nouveaux virus herpes recombinants, vaccin a base de ces recombinants, leur procede de preparation, genes, vecteurs et plasmides utilises dans ce procede.
US6913751B2 (en) 1992-06-12 2005-07-05 Schering-Plough Veterinary Corporation Recombinant avian herpesvirus useful in vaccine production
US5853733A (en) * 1993-02-26 1998-12-29 Syntro Corporation Recombinant herpesvirus of turkeys and uses thereof
US6875856B2 (en) 1993-09-24 2005-04-05 Syntro Corporation Recombinant infectious laryngotracheitis virus and uses thereof
EP0750670A1 (en) * 1994-02-07 1997-01-02 Cornell Research Foundation, Inc. Compositions useful in controlling marek's disease
FR2728795B1 (fr) * 1994-12-30 1997-03-21 Rhone Merieux Vaccin vivant recombinant aviaire, utilisant comme vecteur un virus herpes aviaire
CA2216139C (en) * 1995-03-23 2013-01-08 Syntro Corporation Recombinant infectious laryngotracheitis virus and uses thereof
CA2221570A1 (en) * 1995-06-07 1996-12-19 Aesculaap B.V. Neutralizing conformation epitopes of chicken anemia virus
FR2767335B1 (fr) * 1997-08-14 2001-09-28 Ct Nat D Etudes Veterinaires E Adenovirus aviaire celo recombinant comme vecteur vaccinant
ATE330013T1 (de) 2000-12-20 2006-07-15 Intervet Int Bv Lawsonia intracellularis impfstoff
US7314715B2 (en) 2001-06-14 2008-01-01 Schering-Plough Animal Health Corporation Recombinant avian herpesvirus useful in vaccine production
CA2494197C (en) 2002-08-12 2012-10-09 Akzo Nobel N.V. Streptococcus uberis protein, nucleic acid sequence encoding the same and its use in a mastitis vaccine
CN100334217C (zh) * 2005-08-15 2007-08-29 北京市农林科学院 重组鸡马立克氏病病毒转移载体及应用
EP2412382A1 (en) 2010-07-29 2012-02-01 University Court of the University of Edinburgh Recombinant Trypanosoma theileri parasite
US9139824B2 (en) 2011-04-21 2015-09-22 The University Court Of The University Of Aberdeen Sapolegina protein in for use as a medicament
US10105424B2 (en) 2012-10-09 2018-10-23 Universiteit Gent Cooperia vaccine
EP2845904A1 (en) * 2013-09-06 2015-03-11 Ceva Sante Animale Recombinant Marek's disease viruses and uses thereof
EP3050572A1 (en) 2015-01-29 2016-08-03 Ceva Sante Animale Recombinant MDV1 and the uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2779447B2 (ja) * 1988-03-20 1998-07-23 財団法人阪大微生物病研究会 弱毒マレック病ウイルス・ベクターを用いる組換え遺伝子作成法、及び該ウイルスの組換え体
EP0431668B1 (en) * 1989-12-04 1995-02-15 Akzo Nobel N.V. Recombinant herpesvirus of turkeys and live vector vaccines derived thereof
US6087127A (en) * 1990-08-24 2000-07-11 Board Of Trustees Operating Michigan State University Marek's disease herpesvirus DNA segment encoding glycoproteins, gD, gI and gE

Also Published As

Publication number Publication date
ZA915563B (en) 1992-07-29
CA2047290A1 (en) 1992-01-31
HU912526D0 (en) 1992-01-28
EP0473210A2 (en) 1992-03-04
KR920002782A (ko) 1992-02-28
DE69101683D1 (de) 1994-05-19
JPH06233682A (ja) 1994-08-23
JP3159476B2 (ja) 2001-04-23
HU219377B (en) 2001-03-28
AU645333B2 (en) 1994-01-13
KR0153005B1 (ko) 1998-10-15
CN1056879C (zh) 2000-09-27
EP0473210A3 (en) 1992-06-10
AU8143791A (en) 1992-02-06
EP0473210B1 (en) 1994-04-13
CA2047290C (en) 2002-12-10
NZ239146A (en) 1992-12-23
HUT58371A (en) 1992-02-28
DE69101683T2 (de) 1994-07-21
CN1060680A (zh) 1992-04-29

Similar Documents

Publication Publication Date Title
ES2056565T3 (es) Virus recombinante de la enfermedad de marek.
Tweeten et al. Characterization of an extremely basic protein derived from granulosis virus nucleocapsids
ES2070997T3 (es) Virus de herpes recombinante de pavos y vacunas vector vivas derivadas de los mismos.
DE69125925T2 (de) Rekombinante herpes simplex virus impfstoffe und methoden
ES2145000T3 (es) Virus recombinante del avipox.
ES2059370T3 (es) Un virus herpes simplex recombinante, vacunas y metodos.
ES2052478T1 (es) Particulas retrovirales no replicantes producidas de forma recombinante empleadas como agentes antivirales e inmunogenos.
BR0109530A (pt) Promotores de vìrus de encrespamento de folha amarela de cestrum
CY1106848T1 (el) Τροποποιημενος ιος vaccinia ankara για τον εμβολιασμο νεογνων
ES2066842T3 (es) Virus recombinante de la enfermedad de marek y vacuna.
DK0596979T3 (da) Rekombinante nucleinsyrer fra plantevirus
BR9712592A (pt) Processo para gerar um clone infeccioso, ácido nucléico recombinante, molécula do mesmo, vìrus de rna modificado, célula infectada com o mesmo, vacina, proteìna e/ou antìgeno, e, ensaio diagnóstico
DK605987D0 (da) Bestemte dna-sekvenser afledt af et papillomavirus-genom, deres anvendelse til in vitro diagnoseformaal og fremstilling af antigeniske praeparater
BR0014171A (pt) Composição
EP0261940A3 (en) Pseudorabies vaccines and dna vectors for recombination with pox viruses
UA84667C2 (ru) Вакцина, направленная против инфекции, вызванной вирусом герпеса болезни марека
PT84640B (pt) Vector viral que contem um gene que codifica para uma das glicoproteinas (gp) do involucro do virus responsavel pela s.i.d.a. e anticorpos contra essas glicoproteinas
ES2131050T3 (es) Genes de resistencia a virus/herbicidas, procedimiento para su preparacion y su uso.
DK1071758T3 (da) Porcin adenovirus-vektor
ES2188589T3 (es) Vacuna recombinante del herpes virus felino.
MX9605139A (es) Linea celular de pollo, sostenible, infectada con el virus de la enfermedad de marek.
FR2693472B1 (fr) Mutants du virus de la rhinotrachéite infectieuse bovine, délétés dans l'un des gènes des glycoprotéines mineures, vaccins préparés à partir de ces souches, méthodes de production et méthodes d'utilisation.
MX9602256A (es) Vacuna contra la enfermedad de marek.
ES2060625T3 (es) Virus de papiloma humano del tipo 41.
AR021406A1 (es) Un mutante del virus de la rabia recombinante, y una vacuna antirrabica con virus vivos atenuados

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 473210

Country of ref document: ES